Skip to main content
Symphony Limited logo

Symphony Limited — Investor Relations & Filings

Ticker · SYMPHONY ISIN · INE225D01027 LEI · 3358004KHBEOQRZCFM37 BSE.NS Manufacturing
Open in API
Filings indexed 2,592 across all filing types
Latest filing 2025-04-12 Regulatory Filings
Country IN India
Listing BSE.NS SYMPHONY

About Symphony Limited

https://symphonylimited.com/

Symphony Limited specializes in the design and manufacture of evaporative air cooling solutions for residential, commercial, and industrial applications. The company provides a comprehensive range of products, including portable household coolers, tower coolers, and large-scale industrial cooling systems. Symphony is distinguished by its focus on energy-efficient technology and sustainable cooling alternatives to conventional air conditioning. Its product portfolio incorporates advanced features such as multi-stage air purification systems and high-efficiency cooling media. The company serves a global market, delivering cooling solutions engineered for low power consumption and minimal environmental impact. Through ongoing research and development, Symphony addresses diverse climatic requirements and cooling needs across various sectors, emphasizing performance, durability, and technological innovation in the evaporative cooling domain.

Recent filings

Filing Released Lang Actions
Media Release : Explore the Divestment / Monetization of stakes in Australian and Mexican Subsidiaries
Regulatory Filings
2025-04-12 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a media release announcing the company's board approval to explore divestment/monetization of stakes in subsidiaries in Australia and Mexico. It references a strategic initiative and appointment of investment bankers but does not contain financial statements or detailed financial data. It is an announcement of a capital/financing update related to potential divestment activities. The document is about a financing/capital structure update rather than a full financial report or regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2025-04-12 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a detailed announcement from Symphony Limited about the outcome of a Board Meeting held on April 12, 2025. It discusses strategic decisions including exploring divestment/monetization of stakes in subsidiaries in Australia and Mexico, financial performance data, ROCE percentages, and management focus. It also includes an invitation to a conference call scheduled for April 15, 2025, to discuss the board meeting outcomes, with details of senior management participants and dial-in information. The content is focused on board decisions and management strategy rather than full financial statements or earnings results. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is primarily about board meeting outcomes and management decisions, which fits the category of Board/Management Information (MANG). The length (9131 characters) and detailed content support this classification rather than a brief announcement or a regulatory filing. Therefore, the appropriate classification is MANG with high confidence.
2025-04-12 English
Explore the Divestment / Monetization of stakes in Australian and Mexican subsidiaries
Regulatory Filings
2025-04-12 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the outcome of a board meeting held on April 12, 2025, by Symphony Limited. It discusses strategic decisions including exploring divestment/monetization of stakes in subsidiaries in Australia and Mexico, appointment of investment bankers, and reclassification of investments as assets held for sale. It includes financial performance data and ROCE analysis but does not present a full financial report or comprehensive financial statements. The document also includes an invitation to a conference call scheduled for April 15, 2025, to discuss the board meeting outcomes, with links to a presentation and dial-in details. The content is primarily an official announcement of board decisions and upcoming investor communication rather than a full management report, earnings release, or annual/interim report. Given the focus on board meeting outcomes and strategic decisions, this fits best under Board/Management Information (MANG). The document length (9131 characters) and detailed content support a confident classification as MANG rather than a brief announcement or regulatory filing.
2025-04-12 English
Sale of Technology Know-how and Nine Intellectual Property Rights (IPRs) by GSK to IMPCO
Regulatory Filings
2025-04-12 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.